Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial - Concepedia

Concepedia

Publication | Open Access

Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial

DOI Full Paper Access

42

Citations

15

References

2022

Year

Xuan Ying Poh, Chee Wah Tan, I Russel Lee, Jean‐Marc Chavatte, Siew‐Wai Fong, Tessa Prince, Catherine Hartley, Aileen Ying Yan Yeoh, Suma Rao, Po Ying Chia,

Clinical Infectious Diseases

Abstract

NCT05142319.

References

	Year	Citations

Page 1